Medlyfe Hosts Landmark Regenerative Medicine Conference in Lagos

Medlyfe Wellness and Regenerative Medicine Centre, a premium wellness and regenerative medicine facility and a subsidiary of Medbury Healthcare Group, has successfully hosted a landmark Regenerative Medicine Clinic Conference in Lagos, bringing together international experts, clinicians and healthcare stakeholders to advance responsible regenerative medicine and longevity care in Nigeria.

The conference, held at Four Points by Sheraton, Victoria Island, was themed “Shaping the Future of Medicine” and focused on global standards, clinical innovation, biobanking infrastructure, physician training pathways and ethical governance in regenerative medicine.

Global Experts, Local Impact

The event featured a distinguished international and local faculty, including Dr Veerapol Khemarangsann and Mr Piyawat Ratchapolsitte of the Medeze Group (Thailand), Dr Tatiana Zhelinova, a regenerative medicine expert based in Thailand, Dr Chris Paulus, Executive Director of the American Board of Regenerative Medicine (ABRM), and Dr Adedotun Ajelabi, Head of Medical Services at Medlyfe Wellness and Regenerative Medicine Centre.

Thailand-based biotechnology and biobanking leader Medeze Group participated in the conference as part of exploratory engagements to assess strategic expansion and partnership opportunities in Nigeria.

Thailand–Nigeria Collaboration and Knowledge Transfer

Presentations by Medeze Group focused on global best practices in cell banking and biobanking ecosystems, the clinical and economic applications of cellular and regenerative therapies, sustainable models for regenerative medicine infrastructure in emerging markets, and the role of biotechnology in longevity science and future clinical applications.

Their participation highlighted Nigeria’s growing profile as a destination for advanced healthcare partnerships, biotechnology investment and regulated regenerative medicine practice.

Commitment from the Private Healthcare Sector

Speaking on the significance of the conference, Dr Itunu Akinware, Chief Executive Officer of Medbury Healthcare Group, emphasised the importance of structured innovation in healthcare.

“At Medbury Healthcare Group, we believe the future of medicine lies in responsible innovation where advanced science is matched with strong governance, clinical standards and patient safety,” she said. “This conference reflects our commitment to bringing global expertise into Nigeria while strengthening local capacity and ethical practice.”

She added that regenerative medicine and longevity care represent a critical frontier in healthcare delivery that must be developed deliberately and in alignment with national health priorities.

Public Sector Alignment and Policy Readiness

In a message acknowledging the conference, Hon. Prof. Akin Abayomi, OON, Lagos State Commissioner for Health, underscored the role of responsible private-sector leadership in advancing healthcare innovation.

“Lagos State recognises the importance of innovation in healthcare, particularly in emerging areas such as regenerative and preventive medicine,” he said. “Engagements like this conference are critical for knowledge exchange, capacity building and ensuring that new medical frontiers evolve within appropriate regulatory and ethical frameworks that protect patients and strengthen our health system.”

He reaffirmed the state government’s openness to constructive dialogue with credible healthcare operators contributing to improved quality of care and future-ready health services.

Standards, Ethics and Professional Governance

A major focus of the conference was professional standards and physician credentialing. Dr Chris Paulus of ABRM outlined international benchmarks for regenerative medicine practice, the distinction between ethical, evidence-based therapies and unregulated interventions, training and accreditation pathways for African physicians, and the importance of governance and professional accountability.

These discussions reinforced the need for Nigeria’s regenerative medicine space to align with globally recognised frameworks as the field continues to evolve.

Medlyfe’s Vision for Future-Focused Care

Leading the local clinical narrative, Dr Adedotun Ajelabi said Medlyfe aims to serve as both a convener and clinical anchor in the sector.

“Our responsibility is not only to deliver advanced care, but to help shape how innovation enters the healthcare system,” he said. “By convening global experts and local stakeholders, Medlyfe is contributing to a future where longevity and regenerative medicine are safe, ethical and evidence-driven.”

The conference concluded with a multispecialty roundtable discussion exploring cross-border collaboration opportunities, physician training and upskilling pathways, referral and adoption models, as well as regulatory readiness and ecosystem development.